Alick Pingbei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alick Pingbei Wang has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
Brian J. Drake
4 shared publicationsMalavan Ragulojan
4 shared publicationsRobert Fahed
4 shared publicationsAneesh Karir
Section of Plastic Surgery, Department of Surgery, University of Manitoba, Winnipeg, Canada
3 shared publications- Brian Drake
University of Ottawa
3 shared publications Husain Shakil
University of Toronto
3 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (4)
Beyond the Catheter: Contemporary Aspiration Pump Systems in Neurointerventional Stroke Therapy
Acute ischemic stroke is the greatest cause of morbidity and mortality among cerebrovascular pathologies. Over time, several therapeutic options have been developed for treating patients with stroke, including IV r-tPA (intravenous recombinant tissue-type plasminogen activator) and IV-TNK (intravenous tenecteplase) thrombolysis, and endovascular mechanical thrombectomy, with the latter showing favorable recanalization rates. Stent retrievers and mechanical aspiration, the 2 types of mechanical thrombectomy, are used for acute ischemic stroke due to large-vessel occlusions. The first reported aspiration thrombectomy dates back to 2002, during which a 50 mL syringe was used to generate negative pressure and aspirate a clot. Since then, extensive research and development have transformed aspiration thrombectomy. Penumbra’s first system paved the way for present-day aspiration systems in neurointerventional surgery, such as the Penumbra engine and Thunderbolt aspiration systems. Ongoing innovations have focused on improving access to challenging vascular locations and enabling the removal of large thrombi. Over time, aspiration techniques have also evolved. However, despite successful first-pass complete revascularization, a subset of patients continues to experience poor functional outcomes, highlighting the multifactorial nature of stroke recovery. In this review, we outline in detail the historical development of aspiration pump systems in neuroendovascular surgery, describe the different systems and their technical characteristics, highlight the clinical trials evaluating their efficacy, with particular attention to distinctions between devices, and discuss avenues for future growth.
- 1 July 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (4)
Open AccessBeyond the Catheter: Contemporary Aspiration Pump Systems in Neurointerventional Stroke Therapy
Acute ischemic stroke is the greatest cause of morbidity and mortality among cerebrovascular pathologies. Over time, several therapeutic options have been developed for treating patients with stroke, including IV r-tPA (intravenous recombinant tissue-type plasminogen activator) and IV-TNK (intravenous tenecteplase) thrombolysis, and endovascular mechanical thrombectomy, with the latter showing favorable recanalization rates. Stent retrievers and mechanical aspiration, the 2 types of mechanical thrombectomy, are used for acute ischemic stroke due to large-vessel occlusions. The first reported aspiration thrombectomy dates back to 2002, during which a 50 mL syringe was used to generate negative pressure and aspirate a clot. Since then, extensive research and development have transformed aspiration thrombectomy. Penumbra’s first system paved the way for present-day aspiration systems in neurointerventional surgery, such as the Penumbra engine and Thunderbolt aspiration systems. Ongoing innovations have focused on improving access to challenging vascular locations and enabling the removal of large thrombi. Over time, aspiration techniques have also evolved. However, despite successful first-pass complete revascularization, a subset of patients continues to experience poor functional outcomes, highlighting the multifactorial nature of stroke recovery. In this review, we outline in detail the historical development of aspiration pump systems in neuroendovascular surgery, describe the different systems and their technical characteristics, highlight the clinical trials evaluating their efficacy, with particular attention to distinctions between devices, and discuss avenues for future growth.
- Open Access
- 6 November 2025
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- p. 1-8
Middle Meningeal Artery Embolization for Subdural Hematoma: Systematic Review and Meta-Analysis of Randomized Trials
Objective: Embolization of the middle meningeal artery (EMMA) is an emerging neuroendovascular therapy for chronic subdural hematoma (CSDH). Recently, three landmark randomized trials (MAGIC-MT, EMBOLISE, STEM) were published. We performed a systematic review and meta-analysis of randomized trials for EMMA. Methods: The authors systematically searched MEDLINE, EMBASE, Cochrane and ClinicalTrials.gov (National Library of Medicine) through March 6, 2025. Prospective randomized controlled trials comparing EMMA and standard care versus standard care alone were included. Primary (symptomatic recurrence, symptomatic progression, major adverse event, neurological deterioration, stroke, myocardial infarction and/or death) and secondary endpoints (serious adverse events, stroke, death from any cause and death from neurological causes) were analyzed. The review was registered on PROSPERO (CRD42024512049). Results: Four randomized trials (Lam et al ., MAGIC-MT, EMBOLISE, STEM) were meta-analyzed. A total of 1468 patients were included. The primary endpoint was met in 50 patients (7.5%) in the EMMA group compared to 106 patients (15.5%) in the control group (RR 0.49 [95% CI, 0.36–0.67]; P < 0.001, I 2 = 0.0%), with a number needed to treat of 13. There was no difference in serious adverse events (RR 0.88 [95% CI 0.68–1.13]; P = 0.31, I 2 = 50.2%), stroke (RR 1.51 [95% CI 0.46–5.01]; P = 0.50, I 2 = 0.0%), death from any cause (RR 1.03 [95% CI 0.37–2.85]; P = 0.95, I 2 = 58.1%) or death from neurological causes (RR 1.29 [95% CI 0.53–3.09]; P = 0.58, I 2 = 25.4%). Conclusions: EMMA is effective in reducing symptomatic recurrence, progression and/or reoperation among patients with CSDH and is not associated with a greater incidence of serious adverse events, stroke or death.
- 6 November 2025
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- p. 1-8
Open AccessMiddle Meningeal Artery Embolization for Subdural Hematoma: Systematic Review and Meta-Analysis of Randomized Trials
Objective: Embolization of the middle meningeal artery (EMMA) is an emerging neuroendovascular therapy for chronic subdural hematoma (CSDH). Recently, three landmark randomized trials (MAGIC-MT, EMBOLISE, STEM) were published. We performed a systematic review and meta-analysis of randomized trials for EMMA. Methods: The authors systematically searched MEDLINE, EMBASE, Cochrane and ClinicalTrials.gov (National Library of Medicine) through March 6, 2025. Prospective randomized controlled trials comparing EMMA and standard care versus standard care alone were included. Primary (symptomatic recurrence, symptomatic progression, major adverse event, neurological deterioration, stroke, myocardial infarction and/or death) and secondary endpoints (serious adverse events, stroke, death from any cause and death from neurological causes) were analyzed. The review was registered on PROSPERO (CRD42024512049). Results: Four randomized trials (Lam et al ., MAGIC-MT, EMBOLISE, STEM) were meta-analyzed. A total of 1468 patients were included. The primary endpoint was met in 50 patients (7.5%) in the EMMA group compared to 106 patients (15.5%) in the control group (RR 0.49 [95% CI, 0.36–0.67]; P < 0.001, I 2 = 0.0%), with a number needed to treat of 13. There was no difference in serious adverse events (RR 0.88 [95% CI 0.68–1.13]; P = 0.31, I 2 = 50.2%), stroke (RR 1.51 [95% CI 0.46–5.01]; P = 0.50, I 2 = 0.0%), death from any cause (RR 1.03 [95% CI 0.37–2.85]; P = 0.95, I 2 = 58.1%) or death from neurological causes (RR 1.29 [95% CI 0.53–3.09]; P = 0.58, I 2 = 25.4%). Conclusions: EMMA is effective in reducing symptomatic recurrence, progression and/or reoperation among patients with CSDH and is not associated with a greater incidence of serious adverse events, stroke or death.
- Open Access
- 7 June 2025
- Published by Springer Nature in European Spine Journal
- Vol. 34 (8) , 3294-3303
Endplate preparation for anterior cervical discectomy and fusion: does the amount of endplate removed affect cage subsidence risk?
Purpose: Subsidence after anterior cervical discectomy and fusion (ACDF) is a common complication that may be influenced by the degree of endplate removal prior to cage insertion. The optimal degree of endplate removal remains unclear; therefore, we performed a series of ex vivo experiments to elucidate the relationship between the aggressiveness of endplate preparation and subsidence risk. Methods: Human cadaveric subaxial cervical endplates were partially decorticated either conservatively (n = 10) or aggressively (n = 9). The degree of endplate removal was quantified using microCT. Subsidence was modelled by measuring the strength and stiffness of each specimen when an interbody cage was axially compressed into the endplate. Results: Conservative endplate preparation resulted in less endplate removal than aggressive endplate preparation (mass: 150 vs. 301 mg, p < 0.001; volume: 47 vs. 88mm3, p = 0.01; thickness: 0.02 vs. 0.16 mm, p = 0.004). There was no significant difference between the two groups with respect to endplate strength (2.04 vs. 2.04kN, p = 0.99) or stiffness (2.38 vs. 2.41kN/mm, p = 0.89). Bone mineral density (BMD) was similar between the two groups (271.6 vs. 271.9 mg/cm3, p = 0.98) but positively correlated with endplate strength (effect size 0.68, p = 0.001). Conclusions: When performing partial cervical endplate decortication, the degree of bony endplate removal did not significantly predict endplate integrity during ex vivo compression testing, but greater BMD was associated with increased strength. The degree of endplate removal should be based on individual patient factors and intraoperative findings to achieve the ideal cage-endplate interface.
- 7 June 2025
- Published by Springer Nature in European Spine Journal
- Vol. 34 (8) , 3294-3303
Open AccessEndplate preparation for anterior cervical discectomy and fusion: does the amount of endplate removed affect cage subsidence risk?
Purpose: Subsidence after anterior cervical discectomy and fusion (ACDF) is a common complication that may be influenced by the degree of endplate removal prior to cage insertion. The optimal degree of endplate removal remains unclear; therefore, we performed a series of ex vivo experiments to elucidate the relationship between the aggressiveness of endplate preparation and subsidence risk. Methods: Human cadaveric subaxial cervical endplates were partially decorticated either conservatively (n = 10) or aggressively (n = 9). The degree of endplate removal was quantified using microCT. Subsidence was modelled by measuring the strength and stiffness of each specimen when an interbody cage was axially compressed into the endplate. Results: Conservative endplate preparation resulted in less endplate removal than aggressive endplate preparation (mass: 150 vs. 301 mg, p < 0.001; volume: 47 vs. 88mm3, p = 0.01; thickness: 0.02 vs. 0.16 mm, p = 0.004). There was no significant difference between the two groups with respect to endplate strength (2.04 vs. 2.04kN, p = 0.99) or stiffness (2.38 vs. 2.41kN/mm, p = 0.89). Bone mineral density (BMD) was similar between the two groups (271.6 vs. 271.9 mg/cm3, p = 0.98) but positively correlated with endplate strength (effect size 0.68, p = 0.001). Conclusions: When performing partial cervical endplate decortication, the degree of bony endplate removal did not significantly predict endplate integrity during ex vivo compression testing, but greater BMD was associated with increased strength. The degree of endplate removal should be based on individual patient factors and intraoperative findings to achieve the ideal cage-endplate interface.
- 18 April 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 30 (1) , 161-162
Fluorescence-Guided Cord Transection for Supramaximal Resection of Spinal High-Grade Glioma: 2-Dimensional Operative Video
- 18 April 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 30 (1) , 161-162
Fluorescence-Guided Cord Transection for Supramaximal Resection of Spinal High-Grade Glioma: 2-Dimensional Operative Video
- Open Access
- 10 April 2025
- Published by Elsevier in World Neurosurgery
- Vol. 198, 123969
In Reply to the Letter to the Editor Regarding "Ultrasound-Guided EVD Insertion After Decompressive Craniectomy"
- 10 April 2025
- Published by Elsevier in World Neurosurgery
- Vol. 198, 123969
Open AccessIn Reply to the Letter to the Editor Regarding "Ultrasound-Guided EVD Insertion After Decompressive Craniectomy"
- Open Access
- 19 March 2025
- Published by Elsevier in World Neurosurgery
- Vol. 197, 123915
Ultrasound-Guided External Ventricular Drain Insertion After Decompressive Craniectomy
- 19 March 2025
- Published by Elsevier in World Neurosurgery
- Vol. 197, 123915
Open AccessUltrasound-Guided External Ventricular Drain Insertion After Decompressive Craniectomy
- 26 March 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 102 (6) , e209225
Clinical Reasoning: A 24-Year-Old Woman With Penetrating Neck Injury From a Needlefish
Evaluating patients with a traumatic spinal cord injury can be complicated by other injuries. In this case, a 24-year-old woman injured by a needlefish presented with combined motor and sensory defects, cranial nerve deficits, and a blunt vascular injury. This case highlights the importance of neurologic and vascular localizations and an understanding of spinal cord injuries involving various ascending and descending tracts. Appreciation of these anatomical considerations through this case illustrates the diagnostic approach to neurologic evaluation. While we present a traumatic etiology for multiple neurologic syndromes, this case gives readers an opportunity to develop a comprehensive differential diagnosis and tailor investigations for other relevant etiologies. Readers walking through this stepwise process will ultimately arrive at several distinct but related diagnoses.
- 26 March 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 102 (6) , e209225
Clinical Reasoning: A 24-Year-Old Woman With Penetrating Neck Injury From a Needlefish
Evaluating patients with a traumatic spinal cord injury can be complicated by other injuries. In this case, a 24-year-old woman injured by a needlefish presented with combined motor and sensory defects, cranial nerve deficits, and a blunt vascular injury. This case highlights the importance of neurologic and vascular localizations and an understanding of spinal cord injuries involving various ascending and descending tracts. Appreciation of these anatomical considerations through this case illustrates the diagnostic approach to neurologic evaluation. While we present a traumatic etiology for multiple neurologic syndromes, this case gives readers an opportunity to develop a comprehensive differential diagnosis and tailor investigations for other relevant etiologies. Readers walking through this stepwise process will ultimately arrive at several distinct but related diagnoses.
- Open Access
Middle meningeal artery embolization for subdural hematoma: protocol for a systematic review and meta-analysis of randomized controlled trials
Background Middle meningeal artery embolization is an emerging neuroendovascular therapy for chronic subdural hematoma. Recently, a number of randomized control trials have been conducted to assess the efficacy of middle meningeal artery embolization to reduce the recurrence or progression of chronic subdural hematoma. Methods A systematic review will be conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The authors will systematically search MEDLINE, EMBASE, Cochrane, and ClinicalTrials.gov (National Library of Medicine) for randomized control trials evaluating middle meningeal artery embolization for chronic subdural hematoma. A meta-analysis will be undertaken to compare patients undergoing middle meningeal artery embolization and standard care compared to standard care alone; primary effectiveness endpoints will be symptomatic recurrence, radiographic re-accumulation, or reoperation; secondary safety endpoints will be new disabling stroke, myocardial infarction, or death within 30 days. Discussion This proposed systematic review and meta-analysis will synthesize and appraise available data regarding middle meningeal artery embolization, a novel neurointerventional therapy. Findings will help clinicians, patients, administrators, policy makers to determine the role of this new treatment and its potential benefits. Systematic review registration PROSPERO #CRD42024512049
Open AccessMiddle meningeal artery embolization for subdural hematoma: protocol for a systematic review and meta-analysis of randomized controlled trials
Background Middle meningeal artery embolization is an emerging neuroendovascular therapy for chronic subdural hematoma. Recently, a number of randomized control trials have been conducted to assess the efficacy of middle meningeal artery embolization to reduce the recurrence or progression of chronic subdural hematoma. Methods A systematic review will be conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The authors will systematically search MEDLINE, EMBASE, Cochrane, and ClinicalTrials.gov (National Library of Medicine) for randomized control trials evaluating middle meningeal artery embolization for chronic subdural hematoma. A meta-analysis will be undertaken to compare patients undergoing middle meningeal artery embolization and standard care compared to standard care alone; primary effectiveness endpoints will be symptomatic recurrence, radiographic re-accumulation, or reoperation; secondary safety endpoints will be new disabling stroke, myocardial infarction, or death within 30 days. Discussion This proposed systematic review and meta-analysis will synthesize and appraise available data regarding middle meningeal artery embolization, a novel neurointerventional therapy. Findings will help clinicians, patients, administrators, policy makers to determine the role of this new treatment and its potential benefits. Systematic review registration PROSPERO #CRD42024512049
- Open Access
- 22 August 2023
- Published by Elsevier in World Neurosurgery
- Vol. 179, 109-117
“Instant 3D” Angiography: Novel Technique for Rapid Conversion of 2D Angiograms into 3D Stereoscopic Videos
- 22 August 2023
- Published by Elsevier in World Neurosurgery
- Vol. 179, 109-117
Open Access“Instant 3D” Angiography: Novel Technique for Rapid Conversion of 2D Angiograms into 3D Stereoscopic Videos